Episode 256: ctDNA in Urothelial Studies
Matt Galsky, MD, talks about his new ctDNA study as well as how ctDNA may play a role in upcoming neoadjuvant trials.
Dr. Galsky is an oncologist and director of GU medical oncology at The Tisch Cancer Institute, Mount Sinai.
630 Madison Ave.
Manalapan, NJ 07726
Contributors and Partners
Cancer Nursing Today
Urban Health Today
Blood Cancers Today
© 2023 Mashup Media, LLC. All rights reserved.